FDA Inspection 1224784 — Bankole Osuntokun, M.D.
The FDA completed an inspection of Bankole Osuntokun, M.D. on Nov 16, 2023 in Fort Worth, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Nov 16, 2023
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fort Worth, TX (United States)
Additional Details
Clinical Investigator (CI)